Research in the Department of Ophthalmology is based on the diverse interests and expertise of the research staff:
Research in the Department of Ophthalmology is based on the diverse interests and expertise of the research staff:
Focused on corneal dystrophies. New Zealand's unique population mix has large autosomal dominant families providing the Genetic Eye Disease Investigation Unit (GEDI) a unique opportunity to identify disease-causing genes.
More on Genetic Eye Disease Investigation Unit (GEDI)
The Green Team's research on direct cell-cell communication has led to a re-evaluation of tissue repair processes, providing the opportunity to improve the outcomes of surgical intervention or trauma, and laser corrective surgery. Current research projects include glaucoma flap surgery (with the aim of preventing reclosure) and optic nerve neuropathies.
The University of Auckland's Department of Ophthalmology has established a world leading research programme on corneal dystrophy. Improved understanding of this common, debilitating, eye disease will lead to development of therapies to reduce visual impairment and the need for corneal transplantation.
Understanding the relationship between the corneal surface and the tear film to elucidate the causes of tear film break-up and the resulting dry eye conditions as well as aiding in the development of artificial tear substitutes and contact lenses.
Access to clinical tissue (both normal, through the New Zealand National Eye Bank and donor tissues, and diseased tissue, sampled with donor consent) provides a the CORnEa Laboratory with significant research potential for understanding disease processes and developing novel treatment strategies. This initiative strives to increase our understanding of the fundamental processes essential for generating viable corneal tissues in the laboratory, to enable repair or as a replacement for donor tissues.
Aims to elucidate the changes in protein composition and interaction during the formation of different types of human cataract and thereby provide targets for the development of novel therapeutics.
Currently, successful grants are being used to focus on the following specific research areas: